Viewing StudyNCT00079066



Ignite Creation Date: 2024-05-05 @ 11:32 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00079066
Status: COMPLETED
Last Update Posted: 2023-08-04
First Post: 2004-03-08

Brief Title: Cetuximab Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer
Sponsor: NCIC Clinical Trials Group
Organization: Canadian Cancer Trials Group

Organization Data

Organization: Canadian Cancer Trials Group
Class: NETWORK
Study ID: CO17
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: NCIC Clinical Trials Group
Lead Sponsor Class: NETWORK
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Australasian Gastro-Intestinal Trials Group NETWORK